'''Diphenylpyraline''' ('''DPP'''; sold as '''Allergen''', '''Arbid''', '''Belfene''', '''Diafen''', '''Hispril''', '''Histyn''', '''Lergobine''', '''Lyssipol''', '''Mepiben''', '''Neargal''') is a [[first-generation antihistamine]] with [[anticholinergic]] effects of the [[benzhydryl|diphenyl]][[piperidine]] class.<ref name="isbn3-88763-075-0">{{cite book | author = Swiss Pharmaceutical Society | title = Index Nominum 2000: International Drug Directory (Book with CD-ROM) | publisher = Medpharm Scientific Publishers | location = Boca Raton | year = 2000 | pages = | isbn = 3-88763-075-0 | oclc = | doi = | url = https://books.google.com/books?id=5GpcTQD_L2oC&lpg=PA358&dq=Diphenylpyraline&pg=PA358#v=onepage&q}}</ref><ref name="pmid14039">{{cite journal | vauthors = Puhakka H, Rantanen T, Virolainen E | title = Diphenylpyraline (Lergobine) in the treatment of patients suffering from allergic and vasomotor rhinitis | journal = J Int Med Res | volume = 5 | issue = 1 | pages = 37–41 | year = 1977 | pmid = 14039}}</ref><ref name="pmid2884340">{{cite journal | vauthors = Kubo N, Shirakawa O, Kuno T, Tanaka C | title = Antimuscarinic effects of antihistamines: quantitative evaluation by receptor-binding assay | journal = Japanese Journal of Pharmacology | volume = 43 | issue = 3 | pages = 277–82 |date=March 1987 | pmid = 2884340 | doi = 10.1254/jjp.43.277| url = }}</ref> It is marketed in [[Europe]] for the treatment of [[allergy|allergies]].<ref name="isbn3-88763-075-0" /><ref name="pmid14039" /><ref name="isbn0-444-52166-6">{{cite book | author = Hruby, Victor J. | author2 = Ruben Vardanyan | author3 = Vardanyan, ۊRuben | title = Synthesis of essential drugs | publisher = Elsevier | location = Amsterdam | year = 2006 | pages = | isbn = 0-444-52166-6 | oclc = | doi = | url = https://books.google.com/books?id=Jjc7KYWZdOYC&lpg=PA230&dq=Diphenylpyraline&pg=PA230#v=onepage&q}}</ref> DPP has also been found to act as a [[dopamine reuptake inhibitor]] and produces [[hyperactivity]] in rodents.<ref name="pmid15627433">{{cite journal | vauthors = Lapa G, Mathews T, Harp J, Budygin E, Jones S | title = Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties | journal = Eur J Pharmacol | volume = 506 | issue = 3 | pages = 237–40 | year = 2005 | pmid = 15627433 | doi = 10.1016/j.ejphar.2004.11.017}}</ref> It has been shown to be useful in the treatment of [[Parkinsonism]].<ref name="pmid11137513">{{cite journal | vauthors = Ohno T, Kobayashi S, Hayashi M, Sakurai M, Kanazawa I | title = Diphenylpyraline-responsive parkinsonism in cerebrotendinous xanthomatosis: long-term follow up of three patients | journal = J Neurol Sci | volume = 182 | issue = 2 | pages = 95–7 | year = 2001 | pmid = 11137513 | doi = 10.1016/S0022-510X(00)00441-X}}</ref>
